essential drugs | Zee News

Advertisement

Newsessential drugs

Essential drugs News

13 Jun 2017

GST impact: Prices of many essential drugs to rise up to 2.29%

Prices of majority of essential drugs will increase by up to 2.29 percent when the Goods and Services Tax regime kicks in from next month.

25 May 2017

NPPA fixes ceiling price of 30 more formulations

Drug pricing regulator NPPA has fixed the ceiling price of 30 more formulations, including those used for treatment of hepatitis, heart conditions, infections, fever and pain.

Pharmaceutical companies

08 Apr 2015

Govt allows pharma companies to hike prices of 509 essential drugs

The government has allowed pharmaceutical companies to hike rates of 509 essential medicines used for treating various ailments like diabetes, hepatitis and cancer by 3.84 percent with effect from April 1.

29 Jan 2015

Patented drugs details sought from drug makers for price negotiation

In its drive to fix prices of patented drugs, national drug price regulator NPPA has sought complete details of such medicines sold in the Indian market from drug makers.

18 Dec 2014

615 drugs under control regime, more steps in offing: Govt

Government said that by next month, it will come out with a new list of life-saving drugs whose prices would be controlled.

essential drugs

26 Nov 2014

Concern in RS over rise in prices of essential medicines

The rise in prices of essential medicines, including those used for treatment of tuberculosis, AIDS and diabetes, resulting from price decontrol of 108 drugs was on Wednesday raised in Rajya Sabha with entire Opposition seeking government's response on the matter.

23 Sep 2014

Govt strips pharma pricing regulator's powers to cap non-essential drug prices

The government has stripped drug pricing authority NPPA of powers to cap prices of non- essential drugs after its recent order triggered industry protests.

19 Sep 2014

36 more drugs to be cheaper as govt caps prices

The medicines join the 348 drugs deemed essential and that are therefore subject to price caps.

Loading...

NEWS ON ONE CLICK